Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Beova granted marketing approval in Japan for overactive bladder

Sep. 25, 2018

ASTRID study of enobosarm does not achieve statistical significance on the primary endpoint

Sep. 25, 2018

TAS-303 shows potential as a novel therapeutic agent for stress urinary incontinence

Sep. 20, 2018

Sanofi achieves KEAP1/Nrf2 inhibition with bioavailable small molecules

Sep. 19, 2018

Patient recruitment starts in two phase II trials of DMX-200 in kidney disease

Sep. 18, 2018

Humanized midkine antibody demonstrates efficacy in experimental model of FSGS

Sep. 13, 2018

SuPAR predicts chronic kidney disease progression in Black Americans

Sep. 12, 2018

Daiichi Sankyo discovers bacterial tryptophanase inhibitors

Sep. 10, 2018

BAY-1101042, a potent NO- and heme-independent sGC activator suitable for oral dosing

Sep. 5, 2018

Janssen Pharmaceutica NV synthesizes 5-HT2B receptor antagonists

Sep. 4, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...